top of page
iPharmaCenter
News | Blogs | Healthcare | Consulting
Contact:
info@ipharmacenter.com
Home
Pharma
North America
US FDA Approvals
Canada Drug Healthcare News
APAC
China Drug Approvals
India Drug Approvals
APAC - Drug Approvals
Japan Drug Approvals | Healthcare
Europe
EMA News
LACAM
Brazil - Drug approvals
Healthcare News
US Healthcare News
US Payer News
APAC - Healthcare News
Europe Healthcare News
Lacam Healthcare News
Healthcare Policies
Disease News
Immunology
Oncology
Infections_Vaccines
Cardiovascular
Kidney Diseases
Metabolic Diseases
Women Health
Neurology
Conferences
Others
COVID-19
Contact
All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam
US FDA News
CMS News
India Drug Healthcare
China Drug Approvals
Europe Healthcare News
APAC Drug approvals
US_PayerNews
Australia TGA Approvals
Biosimilars
Radioligand therapy
Chikungunya News
NICE recommendations
G-BA Assessment Outcomes
HAS Assessment Outcomes
Neurology
Immunology
Search
Log in / Sign up
ipharmaservices
12 hours ago
AbbVie and Simcere Zaiming Collaborate to Develop Innovative Treatment for Multiple Myeloma | iPharmaCenter
ipharmaservices
12 hours ago
FDA Approves Omvoh for Crohn’s Disease, Expanding Its Reach in Inflammatory Bowel Disease Treatment | iPharmaCenter
ipharmaservices
12 hours ago
Johnson & Johnson Expands Neuroscience Portfolio with Acquisition of Intra-Cellular Therapies | iPharmaCenter
ipharmaservices
4 days ago
J.P. Morgan Healthcare Conference 2025 | Novartis | Merck | News | Updates
ipharmaservices
Jan 9
Sanofi Reports Positive Results for Subcutaneous Sarclisa, Aiming to Strengthen Competition with Darzalex | iPharmaCenter
ipharmaservices
Jan 9
Top selling cancer drugs of 2024 | Best selling cancer drugs | Top cancer drugs by revenues in 2024 | iPharmaCenter
ipharmaservices
Jan 8
Valo Health and Novo Nordisk Expand Partnership to Develop Treatments for Cardiometabolic Diseases | iPharmaCenter
ipharmaservices
Jan 2
Novartis aims to treat broader patient population with intrathecal onasemnogene abeparvovec | iPharmaCenter
ipharmaservices
Jan 1
Expected best selling drugs of 2025 | Top pharmaceuticals by revenues | iPharmaCenter
ipharmaservices
Dec 27, 2024
Bristol Myers Squibb Reports Positive Results from Phase 3 Trials of Deucravacitinib in Psoriatic Arthritis | iPharmaCenter
ipharmaservices
Nov 12, 2024
After Tavapadon Success in Phase 3 Prakinson's Disease Trial, Emraclidine Fails In Schizophrenia | Shares Tumbles by 12% | iPharmaCenter
ipharmaservices
Nov 12, 2024
Alexion's Koselugo Shows Improved Objective Response Rate in Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
ipharmaservices
Aug 30, 2024
Best selling immunology drugs by revenues | Top immunology drugs | 2024 | iPharmaCenter
ipharmaservices
Aug 5, 2024
Top pharmaceutical companies by revenues in 2024 | Biggest Pharma of 2024 | Top Pharma profits | iPharmaCenter
ipharmaservices
Jul 21, 2024
Expected | Best selling drugs of 2024 | Top selling drugs of 2024 | iPharmaCenter
ipharmaservices
Jul 15, 2024
LEQEMBI (Lecanemab) Receives Approval in Israel for Treating Alzheimer's Disease | iPharmaCenter
ipharmaservices
Jul 8, 2024
Pharmaceutical deals | Acquistions | 2024 | iPharmaCenter
ipharmaservices
Jun 9, 2024
Lilly's Tirzepatide Shows Promise in MASH Treatment, Achieves Notable Results in Phase 2 Study | iPharmaCenter
ipharmaservices
May 30, 2024
Top selling drugs of 2024 | Best selling drugs of 2024 | iPharmaCenter
ipharmaservices
May 30, 2024
European Commission Approves Opdivo with Cisplatin and Gemcitabine for First-Line Treatment of Advanced Urothelial Carcinoma | iPharmaCenter
1
2
3
4
5
bottom of page